Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Brain Amyloid Imaging With Pittsburgh Compound B in Normal Aging, Mild Cognitive Impairment, and Dementia

NCT00950430 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT00950430
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00950430 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Brain Amyloid Imaging With Pittsburgh Compound B in Normal Aging, Mild Cognitive Impairment, and Dementia
Lead sponsor
Mayo Clinic
Phase
Phase 4
Overall status
Enrolling by invitation
Start date
April 30, 2008
Completion date
June 30, 2027
Enrollment
8,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer's disease, dementia with lewy bodies, frontotemporal dementia, vascular dementia